U.S. Stock News

Amalgamated Financial stock barely flinched after earnings, closing up just 1% at US$50.31. The move looks modest compared with what the bank just put on the table. Q2 delivered record net income of US$34.8 million and a strong return on tangible common equity above 16%. The key question for you is whether this restrained price reaction reflects healthy skepticism or an underappreciation of how much earnings power the deposit franchise and balance sheet shift are starting to show. Is...

Freshpet just served up the kind of quarter that makes a 14.6% one day jump in the stock look less like hype and more like a gut level repricing. Heading into the release, shares had already climbed strongly in recent months. The latest print added fuel, with Q2 net sales of US$305.6m and an adjusted gross margin of 48.6% standing out in a crowded pet food aisle. The heart of this story is margin power. Adjusted EBITDA reached US$52.2m as the fresh pet food specialist showed it can turn shelf...

Elanco Animal Health stock inched up 2.4% to US$26.22 after its second quarter report, a measured move for a business that just put a far stronger profit story on the table than its trailing losses suggest. The headline is margin power. Adjusted EBITDA climbed to US$288 million and adjusted gross margin reached 58.1%, even as revenue came in at US$1.37b. Traders reacted calmly to a set of numbers that point to a company still carrying past unprofitability on its back while current quarter...

GLOBALFOUNDRIES stock came into earnings already bruised after a weak month, then dropped another 4.9% to about US$49.50 by Thursday’s close. The market leaned straight into fear even as the headline result told a more balanced story. Revenue reached US$1.786b and non International Financial Reporting Standards gross margin landed near 30%, both key markers for a contract chip manufacturer trying to prove it can turn volume into dependable profit. Today’s move looks driven more by emotion...

Digital Turbine just reminded investors that short term trading and long term narratives are not always aligned. The stock closed at US$9.51 before the results and then rose to US$13.17, a one day jump of about 38%. That kind of move usually signals a reset in expectations rather than a routine quarter. The headline this time is clear. Digital Turbine reported year on year revenue of about US$166 million and higher adjusted earnings before interest, tax, depreciation and amortization...

Vishay Precision Group entered this earnings release with a stock that had already declined over the past month, then the floor gave way. Shares closed at US$73.56 on Thursday, down about 27% in a single session, as investors reacted to a fresh quarterly loss and softening margins. The headline from the release is simple and uncomfortable. Revenue was around US$83.9m, yet Vishay Precision Group reported a net loss of about US$1.7m and lower earnings per share than in recent quarters. The gap...

The market clipped Global Ship Lease by about 2% today, yet the earnings story looks calmer than the share price suggests. Q2 revenue came in at US$198.7m with basic earnings per share of US$2.48, keeping profitability in focus for a container-ship lessor that still reports a trailing net margin of 48.7%. The bigger debate now is not whether Global Ship Lease is profitable. It is whether a stock trading on a P/E of 4.1, with a sizeable gap to a DCF-based value, is being priced on fear of...

When markets are leaning on record levels of leverage, a small shock can quickly turn into a scramble for cash, collateral and exits. That is where both risk and opportunity sit for investors watching stocks tied to prime brokerage, hedge fund financing and trading activity. This article unpacks how that leverage story touches three specific stocks, with one potentially benefiting and two that could face tougher questions. Morgan Stanley (MS) Morgan Stanley is a global financial services...

Perrigo just rose 23.1% in a single session, which indicates sentiment shifted far faster than the underlying story changed. The stock entered this report trading on a low trailing price-to-sales ratio of 0.4x, far below the broader pharmaceuticals group, and investors finally treated that discount as more than background noise. The main focus is profit tone, not revenue. After a string of heavy losses, Perrigo posted Q2 basic earnings per share of US$0.64, and net income from continuing...

Global Indemnity Group stock jumped 4.8% to US$28.52 the first trading day after earnings, which signals investors liked what they saw. The headline is simple: profitability in the core insurance engine looked solid while the expense ratio stayed heavy as the company keeps plowing money into technology and new platforms. Q2 basic earnings per share of US$0.77 and net income of US$11.1m sat on top of a quarter where the accident year combined ratio held comfortably below 100%. For an insurer...

Sysco stock came into the print treading water after a flat month and a small decline over the past week. A 1.7% pop to US$84.21 after the earnings release signals cautious relief rather than euphoria. The market is reacting to one core message: earnings growth held up while margins stayed tight. The key headline is simple. Sysco pushed quarterly revenue to about US$22.1b and delivered adjusted earnings per share of US$1.53 with free cash flow of US$2.1b for the year. The stock’s move...

Palomar Holdings stock slipped about 1.6% today to roughly US$134, even as the company delivered another strong insurance earnings print. Adjusted net income reached US$63.8 million and adjusted earnings per share came in at US$2.36, both firmly higher than a year ago, and management lifted full year adjusted net income guidance again. So the short term price move looks muted, while the longer term story of growing premiums, a sub 80% adjusted combined ratio and high returns on equity remains...

Teradata stock just endured a brutal reset, sliding almost 24% to about US$26 even though the latest quarter showed solid earnings power. Non GAAP operating margin reached 21.5% and non GAAP earnings per share came in at US$0.69, comfortably ahead of guidance. That clash between price and profit is the real story. Over the past month the stock was already under pressure, with the 30 day return down 28%. Now investors are weighing a much cheaper P/E of 5.4x against a business that just...

Uber Technologies just handed investors a sharp reality check. The stock closed at US$68.18, down 5.3% on Thursday, even as the latest quarter showed the company printing US$14.2b in revenue and US$2.4b in net income. The market focused on the hit to confidence. The numbers tell a more complex story. Over the last year Uber converted its scale into US$9.6b of net income and a 17.3% profit margin. That margin sits below the prior year, which keeps pressure on the long view. The key question...

The market wasted no time rewarding J&J Snack Foods. The stock jumped about 7.7% the day after earnings, even as headline net sales for the June quarter came in at US$426 million, which was lower than a year ago. What lit the spark was not top line growth. It was a clean story on margins in a packaged foods business where costs have been a pressure point. Gross margin reached 35.5% and adjusted earnings per share landed at US$1.96. For a company often viewed as a steady snack and frozen...

Regal Rexnord just took a heavy hit. The stock closed at US$220.04 before earnings and then dropped about 17% to roughly US$183.24. That is a sharp reset for a company that had already been under pressure over the past month. The twist is that the headline numbers did not collapse. Q2 2026 basic earnings per share landed at about US$1.75 on revenue of roughly US$1.56b, with trailing P/E around 37.6x. The key question now is whether this selloff reflects short term fear or a longer term...

Avnet stock jumped 5.1% to US$97.22 after earnings, a sharp move for a company often treated as a steady, low‑drama electronics distributor. The market is reacting to one thing above all: the quarter capped FY 2026 with record quarterly sales of US$8.3b and record adjusted earnings per share of US$2.28, which is a powerful finish for a business that lives on thin component margins. Coming into this print, Avnet shares had already logged double digit gains over the past month. Today’s reaction...

Syndax Pharmaceuticals stock closed up 4.4% at US$19.92, a sharp move for a company that came into this week with a slightly negative 30 day return and a soft 90 day run. The headline today is simple: Q2 revenue reached US$72.8m with Revuforj and Niktimvo together delivering US$115m in quarterly commercial sales, and management reiterated that the balance sheet is funded to support late stage programs. Short term traders are reacting to the bounce. Long term investors are likely focused on...

Ascent Industries stock inched up 1.3% to US$15.58 into the first full trading day after earnings, a muted move for a quarter that flipped the income statement from losses to a profit. Q2 basic earnings per share landed at US$0.07 with net sales of US$25.7 million, while adjusted earnings before interest, tax, depreciation and amortization turned positive. The short term reaction looks restrained given that shift. The bigger question now is whether this first profitable quarter in a while...

Owens Corning stock jumped 4.8% to US$152.47 the day after earnings, a confident move for a building products company that has been wrestling with losses over the past year. On the surface, the headline is simple. Q2 2026 delivered about US$2.8b of revenue and adjusted earnings power, with adjusted EBITDA at US$660m and a 24% margin. The key question is how that profitability compares with a still unprofitable trailing twelve months and a valuation that already trades a touch above a...

Recursion Pharmaceuticals stock has struggled over the long haul, with a steep five year share price decline set against valuation checks that still do not mark it out as a clear bargain today. Over the past five years, Recursion Pharmaceuticals has fallen about 87.9%, which puts the current US$3.17 share price in the context of a long period of weak returns for shareholders. Recent collaboration progress with Genentech can support confidence in Recursion Pharmaceuticals' drug discovery...

Essential Utilities came into this earnings print with a stock that has barely moved, up just 0.08% to US$39.59, even after the numbers hit. For a regulated utility often treated as a steady compounder, that flat reaction sits against a quarter where net income of US$105.7 million on US$530.9 million of revenue kept the earnings engine humming. The focus is not the quarterly noise. More notable is that trailing net profit margin now sits at 21.6% while the stock trades on roughly 20.2x...

8x8 stock inched up 3.1% to US$2.31 heading into the first full trading session after earnings, which is a calm move for results that reshaped the profit story. The headline is simple. A communications and contact center platform that spent years in the red just put up Q1 non GAAP operating income of US$18.9m on US$190.2m of revenue and did it while usage driven business expanded sharply. The market is treating that as a routine beat. The numbers suggest a deeper rethink of what this business...

The market cheered BlueLinx Holdings on the open, sending the stock up about 13% to US$72.54, even though this is still a distributor that has been unprofitable over the last year. The headline from Q2 is simple: BlueLinx put real profit back on the board with US$814.1m in net sales and US$0.82 in basic earnings per share, helped by firmer margins in both specialty and structural products. For a stock often framed as a low P/S turnaround story, this quarter’s clean swing to positive earnings...